Home » Author Archive

Hamilton Beach Brands Holding Co (NYSE:HBB) Sees Large Decline in Short Interest

Hamilton Beach Brands Holding Co (NYSE:HBB) was the target of a large decline in short interest during the month of November. As of November 29th, there was short interest totalling 298,100 shares, a decline of 5.4% from the November 14th total of 315,100 shares. Based on an average daily trading volume, of 53,500 shares, the days-to-cover ratio is currently 5.6 days. Currently, 4.7% of the company’s stock are sold short. Separately, Zacks Investment Research lowered Hamilton Beach Brands from a “buy” rating to a “hold”... 
 

Vera Bradley (NASDAQ:VRA) Stock Rating Upgraded by Zacks Investment Research

Vera Bradley (NASDAQ:VRA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Saturday, Zacks.com reports. The firm presently has a $12.00 price objective on the textile maker’s stock. Zacks Investment Research‘s target price indicates a potential upside of 8.30% from the stock’s previous close. According to Zacks, “Vera Bradley Designs, Inc. is a designer, producer, marketer and retailer of accessories for women. Its products include handbags, accessories... 
 

BidaskClub Lowers Tellurian (NASDAQ:TELL) to Strong Sell

BidaskClub cut shares of Tellurian (NASDAQ:TELL) from a sell rating to a strong sell rating in a report released on Friday morning, BidAskClub reports. Several other research firms have also weighed in on TELL. Bank of America lowered shares of Tellurian from a buy rating to a neutral rating in a report on Friday, August 23rd. Morgan Stanley initiated coverage on shares of Tellurian in a report on Friday, September 20th. They set an underweight rating and a $6.00 target price for the company. ValuEngine lowered shares of Tellurian from a buy rating... 
 

Kronos Worldwide, Inc. (NYSE:KRO) Short Interest Update

Kronos Worldwide, Inc. (NYSE:KRO) saw a significant decline in short interest in November. As of November 29th, there was short interest totalling 4,110,000 shares, a decline of 5.3% from the November 14th total of 4,340,000 shares. Currently, 18.5% of the shares of the stock are sold short. Based on an average daily volume of 205,700 shares, the days-to-cover ratio is currently 20.0 days. Several institutional investors and hedge funds have recently modified their holdings of the company. SG Americas Securities LLC increased its holdings in ... 
 

TTEC (NASDAQ:TTEC) Cut to Sell at BidaskClub

BidaskClub lowered shares of TTEC (NASDAQ:TTEC) from a hold rating to a sell rating in a research report report published on Friday, BidAskClub reports. A number of other equities analysts have also weighed in on TTEC. Sidoti initiated coverage on shares of TTEC in a research report on Thursday, September 19th. They set a buy rating for the company. ValuEngine lowered shares of TTEC from a hold rating to a sell rating in a research report on Wednesday, October 2nd. Two equities research analysts have rated the stock with a sell rating, one has... 
 

PDF Solutions (NASDAQ:PDFS) Lifted to Buy at BidaskClub

BidaskClub upgraded shares of PDF Solutions (NASDAQ:PDFS) from a hold rating to a buy rating in a research report released on Friday, BidAskClub reports. A number of other brokerages have also commented on PDFS. Zacks Investment Research raised PDF Solutions from a sell rating to a hold rating in a report on Wednesday, December 11th. Northland Securities reissued a buy rating on shares of PDF Solutions in a report on Friday, November 1st. Finally, Craig Hallum raised PDF Solutions from a hold rating to a buy rating and set a $23.50 price objective... 
 

Surgery Partners (NASDAQ:SGRY) Downgraded by BidaskClub

BidaskClub lowered shares of Surgery Partners (NASDAQ:SGRY) from a strong-buy rating to a buy rating in a report published on Friday, BidAskClub reports. Several other brokerages have also recently weighed in on SGRY. Citigroup raised their price target on shares of Surgery Partners from $13.00 to $20.00 and gave the company a buy rating in a research report on Tuesday, December 10th. ValuEngine cut shares of Surgery Partners from a strong-buy rating to a buy rating in a research report on Tuesday, December 10th. Finally, Zacks Investment Research... 
 

Applied DNA Sciences’ (APDN) Buy Rating Reaffirmed at Maxim Group

Maxim Group restated their buy rating on shares of Applied DNA Sciences (NASDAQ:APDN) in a report released on Friday, AnalystRatings.com reports. Maxim Group currently has a $8.00 price target on the technology company’s stock. Separately, ValuEngine raised shares of Applied DNA Sciences from a hold rating to a buy rating in a report on Tuesday, December 3rd. APDN opened at $3.94 on Friday. The company has a 50 day moving average of $4.17 and a 200 day moving average of $1.32. Applied DNA Sciences has a 12 month low of $3.52 and a 12 month... 
 

Amarin’s (AMRN) Buy Rating Reiterated at Leerink Swann

Leerink Swann reissued their buy rating on shares of Amarin (NASDAQ:AMRN) in a research note issued to investors on Friday, TipRanks reports. They currently have a $29.00 price objective on the biopharmaceutical company’s stock. Other equities analysts also recently issued research reports about the company. Jefferies Financial Group reissued a buy rating and set a $30.00 price target on shares of Amarin in a research report on Friday, November 29th. BidaskClub raised Amarin from a hold rating to a buy rating in a research report on Friday,... 
 

SP Plus (NASDAQ:SP) Cut to “Hold” at BidaskClub

BidaskClub lowered shares of SP Plus (NASDAQ:SP) from a buy rating to a hold rating in a research note published on Friday morning, BidAskClub reports. A number of other equities analysts have also recently issued reports on SP. ValuEngine cut shares of SP Plus from a hold rating to a sell rating in a research report on Thursday, November 21st. Barrington Research boosted their price objective on shares of SP Plus from $43.00 to $51.00 in a research report on Wednesday, November 6th. Finally, Zacks Investment Research upgraded shares of SP Plus... 
 

BidaskClub Lowers Safety Insurance Group (NASDAQ:SAFT) to Strong Sell

BidaskClub downgraded shares of Safety Insurance Group (NASDAQ:SAFT) from a sell rating to a strong sell rating in a research report released on Friday, BidAskClub reports. Separately, ValuEngine cut Safety Insurance Group from a buy rating to a hold rating in a research note on Wednesday, October 2nd. NASDAQ:SAFT opened at $95.86 on Friday. Safety Insurance Group has a 1 year low of $77.58 and a 1 year high of $103.96. The stock has a market cap of $1.47 billion, a price-to-earnings ratio of 16.94 and a beta of 0.54. The business has a fifty day... 
 

Good Times Restaurants’ (GTIM) “Buy” Rating Reiterated at Maxim Group

Maxim Group reiterated their buy rating on shares of Good Times Restaurants (NASDAQ:GTIM) in a research note released on Friday, AnalystRatings.com reports. They currently have a $5.00 price objective on the restaurant operator’s stock. Several other equities research analysts have also recently issued reports on the company. ValuEngine upgraded Good Times Restaurants from a hold rating to a buy rating in a research note on Wednesday, October 2nd. Zacks Investment Research upgraded Good Times Restaurants from a sell rating to a hold rating... 
 

BidaskClub Lowers ePlus (NASDAQ:PLUS) to Sell

BidaskClub lowered shares of ePlus (NASDAQ:PLUS) from a hold rating to a sell rating in a research note issued to investors on Friday morning, BidAskClub reports. Several other research firms have also weighed in on PLUS. Berenberg Bank reiterated a hold rating and set a $91.00 target price on shares of ePlus in a report on Tuesday, November 12th. Sidoti lowered ePlus from a buy rating to a neutral rating and reduced their target price for the stock from $103.00 to $98.00 in a report on Thursday, November 14th. ValuEngine lowered ePlus from a sell... 
 

Monolithic Power Systems, Inc. (NASDAQ:MPWR) Short Interest Down 5.3% in November

Monolithic Power Systems, Inc. (NASDAQ:MPWR) was the recipient of a significant drop in short interest during the month of November. As of November 29th, there was short interest totalling 1,240,000 shares, a drop of 5.3% from the November 14th total of 1,310,000 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average daily trading volume, of 372,300 shares, the days-to-cover ratio is presently 3.3 days. Monolithic Power Systems stock opened at $174.60 on Monday. The firm has a 50-day moving average of $160.53... 
 

WSFS Financial (NASDAQ:WSFS) Lowered to “Sell” at BidaskClub

BidaskClub cut shares of WSFS Financial (NASDAQ:WSFS) from a hold rating to a sell rating in a report issued on Friday morning, BidAskClub reports. A number of other research analysts also recently commented on the company. Zacks Investment Research restated a hold rating on shares of WSFS Financial in a research note on Saturday, October 26th. ValuEngine upgraded WSFS Financial from a strong sell rating to a sell rating in a research note on Tuesday, December 3rd. Finally, Keefe, Bruyette & Woods downgraded WSFS Financial from an outperform... 
 

Xperi (NASDAQ:XPER) Earns “Buy” Rating from B. Riley

B. Riley restated their buy rating on shares of Xperi (NASDAQ:XPER) in a research report released on Friday, TipRanks reports. They currently have a $28.00 price target on the semiconductor company’s stock. XPER has been the subject of several other reports. Zacks Investment Research cut Xperi from a strong-buy rating to a hold rating in a report on Saturday, October 12th. BidaskClub raised Xperi from a strong sell rating to a sell rating in a research note on Friday. Two investment analysts have rated the stock with a sell rating, one has... 
 

Gateley’s (GTLY) Corporate Rating Reaffirmed at FinnCap

FinnCap reaffirmed their corporate rating on shares of Gateley (LON:GTLY) in a research note released on Friday morning, Stock Target Advisor reports. Shares of LON:GTLY opened at GBX 181 ($2.38) on Friday. The company has a current ratio of 1.80, a quick ratio of 1.69 and a debt-to-equity ratio of 20.01. The company has a fifty day simple moving average of GBX 165.59 and a 200 day simple moving average of GBX 163.58. The firm has a market cap of $205.80 million and a PE ratio of 15.60. Gateley has a 12-month low of GBX 118.40 ($1.56) and a 12-month... 
 

Imperial Brands’ (IMB) “Buy” Rating Reiterated at Jefferies Financial Group

Jefferies Financial Group reaffirmed their buy rating on shares of Imperial Brands (LON:IMB) in a report published on Friday morning, Stock Target Advisor reports. Several other brokerages have also recently issued reports on IMB. Deutsche Bank reissued a buy rating on shares of Imperial Brands in a research report on Friday, August 16th. Credit Suisse Group reduced their price target on shares of Imperial Brands from GBX 3,300 ($43.41) to GBX 3,000 ($39.46) and set an outperform rating on the stock in a research report on Wednesday, November... 
 

HSBC Cuts John Laing Group (LON:JLG) Price Target to GBX 369

John Laing Group (LON:JLG) had its target price cut by HSBC from GBX 389 ($5.12) to GBX 369 ($4.85) in a report published on Friday morning, Stock Target Advisor reports. They currently have a hold rating on the stock. Several other research analysts have also weighed in on the company. Peel Hunt reaffirmed a buy rating on shares of John Laing Group in a research report on Monday, December 9th. Barclays boosted their price target on John Laing Group from GBX 430 ($5.66) to GBX 440 ($5.79) and gave the stock an equal weight rating in a research... 
 

PureTech Health’s (PRTC) “Buy” Rating Reaffirmed at Peel Hunt

Peel Hunt reissued their buy rating on shares of PureTech Health (LON:PRTC) in a research note issued to investors on Friday morning, ThisIsMoney.Co.Uk reports. PRTC has been the topic of several other reports. Peel Hunt upped their target price on shares of PureTech Health from GBX 380 ($5.00) to GBX 460 ($6.05) and gave the company a buy rating in a research report on Friday, November 22nd. Liberum Capital restated a buy rating on shares of PureTech Health in a research report on Monday, December 9th. Shares of LON PRTC opened at GBX 279 ($3.67)... 
 

Stratasys (NASDAQ:SSYS) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of Stratasys (NASDAQ:SSYS) from a sell rating to a hold rating in a research note published on Thursday, BidAskClub reports. Several other research firms have also recently commented on SSYS. ValuEngine upgraded Stratasys from a sell rating to a hold rating in a research note on Monday, November 4th. Loop Capital cut their target price on Stratasys to $18.00 and set a hold rating on the stock in a research note on Thursday, November 14th. William Blair restated a sell rating on shares of Stratasys in a research note on... 
 

Echostar (NASDAQ:SATS) Downgraded by BidaskClub to “Sell”

BidaskClub downgraded shares of Echostar (NASDAQ:SATS) from a hold rating to a sell rating in a report published on Thursday, BidAskClub reports. SATS has been the subject of a number of other research reports. Raymond James reaffirmed a strong-buy rating and issued a $61.00 target price (down previously from $68.00) on shares of Echostar in a report on Wednesday, September 11th. ValuEngine cut Echostar from a buy rating to a hold rating in a report on Monday, November 4th. Zacks Investment Research raised Echostar from a strong sell rating to... 
 

Digi International Inc. (NASDAQ:DGII) Given Average Rating of “Buy” by Brokerages

Digi International Inc. (NASDAQ:DGII) has earned a consensus recommendation of “Buy” from the nine research firms that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $20.17. A number of research analysts recently commented on DGII shares. BidaskClub raised Digi International from a... 
 

Theravance Biopharma Inc (NASDAQ:TBPH) Receives Average Rating of “Hold” from Analysts

Shares of Theravance Biopharma Inc (NASDAQ:TBPH) have earned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $34.50. Several brokerages have commented on TBPH. BidaskClub upgraded shares of Theravance Biopharma from a “sell”... 
 

AstraZeneca (LON:AZN) Stock Rating Reaffirmed by Shore Capital

Shore Capital reissued their buy rating on shares of AstraZeneca (LON:AZN) in a research report report published on Thursday, ThisIsMoney.Co.Uk reports. A number of other equities analysts have also issued reports on the stock. Societe Generale reiterated a buy rating on shares of AstraZeneca in a research report on Tuesday, September 10th. Kepler Capital Markets upped their price target on shares of AstraZeneca from GBX 7,700 ($101.29) to GBX 8,000 ($105.24) and gave the company a buy rating in a report on Tuesday, October 29th. Jefferies Financial... 
 

Liberum Capital Reaffirms Buy Rating for Hollywood Bowl Group (LON:BOWL)

Liberum Capital restated their buy rating on shares of Hollywood Bowl Group (LON:BOWL) in a research report sent to investors on Friday, Stock Target Advisor reports. A number of other equities analysts have also recently issued reports on BOWL. JPMorgan Chase & Co. lifted their target price on shares of Hollywood Bowl Group from GBX 260 ($3.42) to GBX 270 ($3.55) and gave the stock an overweight rating in a research report on Wednesday, October 9th. Peel Hunt cut shares of Hollywood Bowl Group to an add rating in a research report on Monday,... 
 

United States Lime & Minerals (NASDAQ:USLM) Downgraded by BidaskClub to “Hold”

United States Lime & Minerals (NASDAQ:USLM) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Monday, BidAskClub reports. Separately, ValuEngine cut shares of United States Lime & Minerals from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. United States Lime & Minerals stock opened at $85.99 on Monday. United States Lime & Minerals has a 1 year low of $68.20 and a 1 year... 
 

Jefferies Financial Group Reiterates Buy Rating for Assura (LON:AGR)

Jefferies Financial Group reiterated their buy rating on shares of Assura (LON:AGR) in a report issued on Friday morning, Stock Target Advisor reports. Several other analysts also recently weighed in on the stock. Berenberg Bank began coverage on shares of Assura in a research note on Friday, November 29th. They set a hold rating and a GBX 75 ($0.99) price target for the company. Liberum Capital reaffirmed a hold rating on shares of Assura in a research note on Friday, December 6th. Peel Hunt reaffirmed a hold rating on shares of Assura in a... 
 

Quidel (NASDAQ:QDEL) Downgraded by BidaskClub

Quidel (NASDAQ:QDEL) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Monday, BidAskClub reports. Other analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of Quidel from a “sell” rating to a “hold” rating in a report on Saturday. Canaccord Genuity reaffirmed a “buy” rating and issued a $75.00 price target (up from $70.00) on shares of Quidel in a report on Sunday, November 17th.... 
 

BidaskClub Downgrades Novocure (NASDAQ:NVCR) to Sell

Novocure (NASDAQ:NVCR) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Monday, BidAskClub reports. A number of other research firms have also weighed in on NVCR. Oppenheimer raised their target price on Novocure from $85.00 to $97.00 and gave the company a “buy” rating in a report on Friday, September 13th. ValuEngine lowered Novocure from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd.... 
 

JPMorgan Chase & Co. Reiterates Buy Rating for British American Tobacco Plc Ads (LON:BATS)

JPMorgan Chase & Co. reissued their buy rating on shares of British American Tobacco Plc Ads (LON:BATS) in a research report sent to investors on Friday, Borsen Zeitung reports. BATS has been the subject of a number of other reports. UBS Group set a GBX 3,950 ($51.96) target price on British American Tobacco Plc Ads and gave the company a buy rating in a research note on Thursday, November 28th. Bank of America set a GBX 2,400 ($31.57) target price on British American Tobacco Plc Ads and gave the company a sell rating in a research note... 
 

Credit Suisse Group Reiterates €85.00 Price Target for Henkel AG & Co KGaA (FRA:HEN3)

Credit Suisse Group set a €85.00 ($98.84) target price on Henkel AG & Co KGaA (FRA:HEN3) in a research report released on Friday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock. Several other equities analysts have also commented on HEN3. Warburg Research set a €90.00 ($104.65) price objective on shares of Henkel AG & Co KGaA and gave the stock a neutral rating in a report on Wednesday, November 20th. Nord/LB set a €85.00 ($98.84) target price on shares of Henkel AG & Co KGaA... 
 

Codemasters Group’s (CDM) “Buy” Rating Reiterated at Liberum Capital

Liberum Capital restated their buy rating on shares of Codemasters Group (LON:CDM) in a report released on Friday, ThisIsMoney.Co.Uk reports. Other equities analysts have also recently issued research reports about the stock. Shore Capital reaffirmed a buy rating on shares of Codemasters Group in a research report on Tuesday, November 26th. Berenberg Bank increased their price objective on shares of Codemasters Group from GBX 290 ($3.81) to GBX 380 ($5.00) and gave the stock a buy rating in a research report on Friday, December 6th. Finally, Peel... 
 

MITIE GRP PLC/ADR (OTCMKTS:MITFY) Lowered to “Strong Sell” at ValuEngine

MITIE GRP PLC/ADR (OTCMKTS:MITFY) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued on Monday, ValuEngine reports. Separately, Zacks Investment Research upgraded MITIE GRP PLC/ADR from a “hold” rating to a “buy” rating and set a $7.00 price target for the company in a research report on Wednesday, December 4th. OTCMKTS:MITFY opened at $7.41 on Monday. The business has a fifty day simple moving average of $7.26 and a two-hundred... 
 

Dmc Global (NASDAQ:BOOM) Rating Increased to Buy at BidaskClub

Dmc Global (NASDAQ:BOOM) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Monday, BidAskClub reports. Other research analysts have also recently issued reports about the company. Sidoti set a $79.00 target price on Dmc Global and gave the stock a “buy” rating in a research report on Friday, September 27th. Zacks Investment Research lowered Dmc Global from a “hold” rating to a “sell” rating in a research note on Monday,... 
 

Financial Review: IGM Biosciences (NASDAQ:IGMS) and Advanz Pharma (NASDAQ:CXRXF)

IGM Biosciences (NASDAQ:IGMS) and Advanz Pharma (OTCMKTS:CXRXF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk and dividends. Institutional & Insider Ownership 34.8% of IGM Biosciences shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the... 
 

$0.13 EPS Expected for NGL Energy Partners LP (NYSE:NGL) This Quarter

Equities analysts expect NGL Energy Partners LP (NYSE:NGL) to announce earnings of $0.13 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for NGL Energy Partners’ earnings. The highest EPS estimate is $0.13 and the lowest is $0.12. NGL Energy Partners reported earnings of $0.64 per share in the same quarter last year, which suggests a negative year over year growth rate of 79.7%. The company is expected to issue its next earnings report on Monday, February 10th. On average, analysts... 
 

Financial Contrast: Colony Credit Real Estate (NYSE:CLNC) and Ventas (NYSE:VTR)

Colony Credit Real Estate (NYSE:CLNC) and Ventas (NYSE:VTR) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 27.5% of Colony Credit Real Estate shares are held by institutional investors. Comparatively, 88.1% of Ventas shares are held by institutional investors. 0.3% of Colony Credit Real Estate shares are held by company insiders.... 
 

Financial Comparison: CENTRAIS ELETRI/S (NYSE:EBR.B) & Brookfield Renewable Partners (NYSE:BEP)

CENTRAIS ELETRI/S (NYSE:EBR.B) and Brookfield Renewable Partners (NYSE:BEP) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Risk & Volatility CENTRAIS ELETRI/S has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, Brookfield Renewable Partners has a beta of 0.52, suggesting that its stock price is... 
 

Analyzing Independent Bank Group (NASDAQ:IBTX) and CVB Financial (NASDAQ:CVBF)

Independent Bank Group (NASDAQ:IBTX) and CVB Financial (NASDAQ:CVBF) are both mid-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends. Risk & Volatility Independent Bank Group has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, CVB Financial has a beta of 1.07, meaning that its share price is 7% more volatile... 
 

Goldman Sachs Group Analysts Give Evonik Industries (FRA:EVK) a €30.10 Price Target

Goldman Sachs Group set a €30.10 ($35.00) price target on Evonik Industries (FRA:EVK) in a report released on Friday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock. A number of other research analysts also recently issued reports on EVK. JPMorgan Chase & Co. set a €29.00 ($33.72) price objective on Evonik Industries and gave the company a buy rating in a research note on Thursday. Credit Suisse Group set a €25.00 ($29.07) price objective on Evonik Industries and gave the company a neutral rating... 
 

Deutsche Post (FRA:DPW) PT Set at €40.00 by Deutsche Bank

Deutsche Bank set a €40.00 ($46.51) price target on Deutsche Post (FRA:DPW) in a report published on Thursday, Borsen Zeitung reports. The firm currently has a buy rating on the stock. Several other research analysts have also recently commented on DPW. JPMorgan Chase & Co. set a €25.36 ($29.49) price target on shares of Deutsche Post and gave the stock a sell rating in a report on Tuesday, November 12th. Goldman Sachs Group set a €45.00 ($52.33) price target on shares of Deutsche Post and gave the stock a buy rating in a... 
 

Henkel AG & Co KGaA (FRA:HEN3) Given a €83.00 Price Target by UBS Group Analysts

UBS Group set a €83.00 ($96.51) price target on Henkel AG & Co KGaA (FRA:HEN3) in a research report report published on Friday, Borsen Zeitung reports. The firm currently has a sell rating on the stock. A number of other research firms have also recently issued reports on HEN3. Kepler Capital Markets set a €88.00 ($102.33) target price on Henkel AG & Co KGaA and gave the company a neutral rating in a research note on Thursday, November 14th. Deutsche Bank set a €90.00 ($104.65) target price on Henkel AG & Co KGaA... 
 

Goldman Sachs Group Analysts Give Henkel AG & Co KGaA (FRA:HEN3) a €90.00 Price Target

Goldman Sachs Group set a €90.00 ($104.65) price objective on Henkel AG & Co KGaA (FRA:HEN3) in a research note released on Friday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock. A number of other research firms have also recently issued reports on HEN3. Warburg Research set a €90.00 ($104.65) price target on shares of Henkel AG & Co KGaA and gave the stock a neutral rating in a report on Wednesday, November 20th. Deutsche Bank set a €90.00 ($104.65) target price on shares of... 
 

JPMorgan Chase & Co. Analysts Give Fraport AG Frankfurt Arprt Svcs Wrldwde (FRA:FRA) a €71.00 Price Target

JPMorgan Chase & Co. set a €71.00 ($82.56) price objective on Fraport AG Frankfurt Arprt Svcs Wrldwde (FRA:FRA) in a research note published on Friday, Borsen Zeitung reports. The firm currently has a sell rating on the stock. A number of other analysts have also recently weighed in on FRA. HSBC set a €88.00 ($102.33) price target on Fraport AG Frankfurt Arprt Svcs Wrldwde and gave the company a buy rating in a research report on Tuesday, November 12th. Barclays set a €67.00 ($77.91) price target on Fraport AG Frankfurt Arprt... 
 

Jenoptik (ETR:JEN) Given a €28.00 Price Target by Deutsche Bank Analysts

Deutsche Bank set a €28.00 ($32.56) price objective on Jenoptik (ETR:JEN) in a report released on Friday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock. Several other analysts also recently commented on JEN. Kepler Capital Markets set a €25.00 ($29.07) price target on shares of Jenoptik and gave the company a neutral rating in a research report on Friday, November 22nd. DZ Bank reiterated a neutral rating on shares of Jenoptik in a research report on Wednesday, November 27th. Warburg Research ... 
 

Brenntag (FRA:BNR) Given a €55.00 Price Target by JPMorgan Chase & Co. Analysts

JPMorgan Chase & Co. set a €55.00 ($63.95) target price on Brenntag (FRA:BNR) in a research report report published on Thursday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock. Several other equities research analysts also recently weighed in on BNR. Kepler Capital Markets set a €55.00 ($63.95) price target on shares of Brenntag and gave the company a buy rating in a research report on Wednesday, November 13th. Bankhaus Lampe set a €54.00 ($62.79) price target on shares of Brenntag and gave... 
 

JPMorgan Chase & Co. Reaffirms Buy Rating for Beiersdorf (ETR:BEI)

JPMorgan Chase & Co. reiterated their buy rating on shares of Beiersdorf (ETR:BEI) in a research note published on Friday, Borsen Zeitung reports. Other analysts have also recently issued reports about the company. Goldman Sachs Group set a €100.00 ($116.28) price objective on Beiersdorf and gave the company a sell rating in a research report on Tuesday, October 29th. Kepler Capital Markets set a €104.00 ($120.93) price objective on Beiersdorf and gave the company a neutral rating in a research report on Tuesday, October 29th.... 
 

JPMorgan Chase & Co. Reiterates “CHF 120” Price Target for Nestlé (VTX:NESN)

JPMorgan Chase & Co. set a CHF 120 price objective on Nestlé (VTX:NESN) in a research note published on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock. NESN has been the subject of a number of other reports. Morgan Stanley set a CHF 120 price objective on shares of Nestlé and gave the company a buy rating in a report on Thursday, October 17th. Barclays set a CHF 115 price objective on shares of Nestlé and gave the company a buy rating in a report on Thursday, September 26th. HSBC set a... 
 

Seattle Genetics, Inc. to Post Q4 2020 Earnings of ($0.07) Per Share, Oppenheimer Forecasts (NASDAQ:SGEN)

Seattle Genetics, Inc. (NASDAQ:SGEN) – Investment analysts at Oppenheimer issued their Q4 2020 earnings per share estimates for Seattle Genetics in a research report issued on Thursday, December 12th. Oppenheimer analyst S. Tuerkcan expects that the biotechnology company will post earnings of ($0.07) per share for the quarter. Oppenheimer has a “Outperform” rating and a $124.00 price objective on the stock. Oppenheimer also issued estimates for Seattle Genetics’ FY2022 earnings at $3.70 EPS and FY2023 earnings at $5.39... 
 
© 2006-2019 Ticker Report